Clinical trials
Phase 1 Esophageal Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Completed | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| Eli Lilly and Company | 1 |
| Five Prime Therapeutics, Inc. | 1 |
| Genentech, Inc. | 1 |
| Revolution Medicines, Inc. | 1 |
| SK Life Science, Inc. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Zymeworks BC Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 12 |
| Stomach Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Ovarian Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Colorectal Neoplasms | 5 |
| Pancreatic Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.